AEON.WS

AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS

Overview Fund Activity
Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

53 hedge funds and large institutions have $5.67M invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
3
Calls
$995K
Puts
–
Net Calls
+$995K
Net Calls Change
-$5K

Top Buyers

1
PC
1
Periscope Capital
Ontario, Canada
$32K
2
Parallax Volatility Advisers
2
Parallax Volatility Advisers
California
$87K
3
Calamos Advisors
3
Calamos Advisors
Illinois
$6K
4
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$3K
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1K

Top Sellers

1
FTCM
1
Fir Tree Capital Management
New York
$0
2
AR
2
Advisory Research
Illinois
$0
3
CC
3
Centiva Capital
New York
$0
4
UOC
4
UBS O'Connor
Illinois
$8K
5
Citadel Advisors
5
Citadel Advisors
Florida
$8K
Name Holding Trade Value Shares
Change 		Shares
Change %
AR
51
Advisory Research
Illinois
– -$8K -50,119 Closed
CC
52
Centiva Capital
New York
– -$4K -26,732 Closed
1 2
3